"Open Access" Social Media Guidelines for Pharma A Review and Commentary by John MackHealth Social Media...
Although nearly two-thirds of respondents to a 2009/2010 Pharma Marketing News survey thought that using Twitter for patient support activities would be somewhat or very effective, relatively few pharmaceutical companies are doing this on a regular basis. From time to time, however, it does happen. Boehringer Ingelheim Shows How It's Done
FDA Plans to Do Two Studies to Find Out
Pharma marketers in the U.S. sometimes use celebrities as spokespeople for their branded drugs or for non-branded campaigns. Such celebrities include TV personalities, athletes, movie stars and others who have thousands or millions of fans, Twitter followers, etc. Should Pharma Disclose Payments to Celebrity Spokespeople? This is just one of the issues explored in a recent survey of Pharma Marketing News readers.
Google launched a new drug search result format that includes data from the U.S. FDA, the National Library of Medicine, and the Department of Veterans Affairs, among othersbut apparently not directly from pharmaceutical companies.
Drugmakers dissatisfied with the FDA's use of guidances as a form of policymaking -- including long-awaited guidance for use of social media by the pharmaceutical industry -- could find legal ammunition against the practice. This article presents the relevant case information.
The distribution of medical reprints to healthcare professionals (HCPs) by sales reps is not only a logistical problem but a channel problem as well. Reprints Desk helps pharmaceutical companies to deploy copyrighted e-prints and other marketing materials via iPads and other tablets, or via their own apps and websites in a controlled manner as part of a multichannel marketing campaign.
Whether or not it is
Welcome to Volume 11, Issue #5 (31 MAY 2012) of Pharma Marketing News.
You don't need a crystal ball to know that the future of media is mobile. While pharmaceutical companies may not yet be advertising on mobile devices as they do on TV, websites, and magazines, they are developing health apps that run on Droid smartphones, iPhones and iPads. Many observers feel that the pharma industry lags behind other industries as far as having a mobile strategy is concerned. One of the factors that may be holding back pharma in its pursuit of a mobile strategy is the loomimg sepecter of FDA regulations.